NCT05635643CHS-114toripalimabhead and neck squamous cell carcinomaadvanced solid tumorsHNSCC
…onment (TME) to promote antitumor immunity. An ongoing Phase 1 (NCT05635643), single-agent and toripalimab (tori) combination dose escalati…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT05635643 ×
NCT05635643
This institution is selected. Its supporting articles are shown below.